최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기한국식품영양학회지 = The Korean journal of food and nutrition, v.26 no.3, 2013년, pp.375 - 382
허진우 (유한대학 식품영양과) , 조은희 (유한대학 식품영양과) , 이보경 (유한대학 식품영양과) , 이의영 (산야초 농원) , 윤택준 (유한대학 식품영양과)
The present study is designed to explore an anti-tumor activity on crude extracts of Oplopanax elatus. Water extractions of Oplopanax elatus were performed at
Ahmad M, Rees RC, Ali SA. 2004. Escape from immunotherapy: possible mechanisms that influence tumor regression/progression. Cancer Immunol Immunother 53:844-854
Bisht M, Bist SS, Dhasmana DC. 2010. Biological response modifiers: current use and future prospects in cancer therapy. Indian J Cancer 247:443-451
Chino A, Sakurai H, Choo MK, Koizumi K, Shimada Y, Terasawa K, Saiki I. 2005. Juzentaihoto, a kampo medicine, enhances IL-12 production by modulating toll-like receptor 4 signaling pathways in murine peritoneal exudate macrophages. Int Immunopharmacol 5:871-882
Dethlefsen C, Hojfeldt G, Hojman P. 2013. The role of intratumoral and systemic IL-6 in breast cancer. Breast Cancer Res Treat 138:657-664
Fisher M, Yang LX. 2002. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res 22:1737-1754
Gough MJ, Melcher AA, Ahmed A, Crittenden MR, Riddle DS, Linardakis E, Ruchatz AN, Emiliusen LM, Vile RG. 2001. Macrophages orchestrate the immune response to tumor cell death. Cancer Res 61:7240-7247
Gutzmer R, Li W, Sutterwala S, Lemos MP, Elizalde JI, Urtishak SL, Behrens EM, Rivers PM, Schlienger K, Laufer TM, Eck SL, Marks MS. 2004. A tumor-associated glycoprotein that blocks MHC class II dependent antigen presentation by dendritic cells. J Immunol 173:1023-3102
Han KH, Kim DH, Song KY, Lee KH, Kang TB, Yoon TJ. 2012. Enhancement of anti-tumor immunity by administration of Macrolepiota procera extracts. Kor J Pharmacogn 43: 32-38
Inatsu A, Kinoshita M, Nakashima H, Shimizu J, Saitoh D, Tamai S, Seki S. 2009. Novel mechanism of C-reactive protein for enhancing mouse liver innate immunity. Hepatology 49: 2044-2054
Knutson KL, Disis ML. 2005. Tumor antigen-specific T helper cells in cancer immunity and immunotherapy. Cancer Immunol Immunother 54:721-728
Kwon HS, Kim DH, Shin HY, Yu CY, Kim MJ, Lim JD, Park JK, Kim JK. 2007. Fourteen-day repeated-dose oral toxicity study of the ethanol extracts isolated from Oplopanax elutus in Sprague-Dawley rat. Korean J Food Sci Technol 39: 470-475
Li XL, Sun S, Du GJ, Qi LW, Williams S, Wang CZ, Yuan CS. 2010. Effects of Oplopanax horridus on human colorectal cancer cells. Anticancer Res 30:295-302
McCutcheon AR, Ellis SM, Hancock RE, Towers GH. 1992. Antibiotic screening of medicinal plants of the British Columbian native peoples. J Ethnopharmacol 37:213-223
McCutcheon AR, Roberts TE, Gibbons E, Ellis SM, Babiuk LA, Hancock RE, Towers GH. 1995. Antiviral screening of British Columbian medicinal plants. J Ethnopharmacol 49: 101-110
Miconnet I, Koenig S, Speiser D, Krieg A, Guillaume P, Cerottini JC, Romero P. 2002. CpG are efficient adjuvants for specific CTL induction against tumor antigen derived peptide. J Immunol 168:1212-1218
Murray HW, Nathan CF. 1999. Macrophage microbicidal mechanisms in vivo: reactive nitrogen versus oxygen intermediates in the killing of intracellular visceral Leishmania donovani. J Exp Med 189:741-746
Ohno N, Furukawa M, Miura NN, Adachi Y, Motoi M, Yadomae T. 2001. Antitumor beta glucan from the cultured fruit body of Agaricus blazei. Biol Pharm Bull 24:820-828
Stauder H, Kreuser ED. 2002. Mistletoe extracts standardised in terms of mistletoe lectins (ML I) in oncology: current state of clinical research. Onkologie 25:374-380
Strome SE, Voss S, Wilcox R, Wakefield TL, Tamada K, Flies D, Chapoval A, Lu J, Kasperbauer JL, Padley D, Vile R, Gastineau D, Wettstein P, Chen L. 2002. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Cancer Res 62:1884-1889
Sun S, Du GJ, Qi LW, Williams S, Wang CZ, Yuan CS. 2010. Hydrophobic constituents and their potential anticancer activities from Devil's Club (Oplopanax horridus Miq.). J Ethnopharmacol 132:280-285
Trinchieri G. 1995. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276
Wasser SP. 2002. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides. Appl Microbiol Biot 60:258-274
Watford WT, Moriguchi M, Morinobu A, O'Shea JJ. 2003. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev 14:361-368
Weiss JM, Subleski JJ, Wigginton JM, Wiltrout RH. 2007. Immunotherapy of cancer by IL-12-based cytokine combinations. Expert Opin Biol Ther 7:1705-1721
Wolfers J, Lozier A, Raposo G, Regnault A, Thery C, Masurier C, Flament C, Pouzieux S, Faure F, Tursz T, Angevin E, Amigorena S, Zitvogel L. 2001. Tumor derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med 7:297-303
Yang MC, Kwon HC, Kim YJ, Lee KR, Yang HO. 2010. Oploxynes A and B, polyacetylenes from the stems of Oplopanax elatus. J Nat Prod 73: 801-805
Yoon TJ 2008. Effect of water extracts from root of Taraxacum officinale on innated and adoptive immune response in mice. Korean J Food & Nutr 21:275-282
Yoon TJ, Kim JY, Kim H, Hong C, Lee H, Lee CK, Lee KH, Hong S, Park SH. 2008. Anti-tumor immunostimulatory effect of heat-killed tumor cells. Exp Mol Med 40:130-144
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.